366 related articles for article (PubMed ID: 37064609)
21. Imaging of atherosclerosis: magnetic resonance imaging.
Corti R; Fuster V
Eur Heart J; 2011 Jul; 32(14):1709-19b. PubMed ID: 21508002
[TBL] [Abstract][Full Text] [Related]
22. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
[TBL] [Abstract][Full Text] [Related]
23. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
[No Abstract] [Full Text] [Related]
24. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
Kang WJ
Korean J Radiol; 2015; 16(6):1257-61. PubMed ID: 26576114
[TBL] [Abstract][Full Text] [Related]
25. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
26. Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
Bala G; Blykers A; Xavier C; Descamps B; Broisat A; Ghezzi C; Fagret D; Van Camp G; Caveliers V; Vanhove C; Lahoutte T; Droogmans S; Cosyns B; Devoogdt N; Hernot S
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):1001-8. PubMed ID: 26800768
[TBL] [Abstract][Full Text] [Related]
27. Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle.
Tu Y; Ma X; Chen H; Fan Y; Jiang L; Zhang R; Cheng Z
Int J Nanomedicine; 2022; 17():6773-6789. PubMed ID: 36600879
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion.
Abd-Elrahman I; Kosuge H; Wises Sadan T; Ben-Nun Y; Meir K; Rubinstein C; Bogyo M; McConnell MV; Blum G
PLoS One; 2016; 11(8):e0160522. PubMed ID: 27532109
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid-modified mesoporous silica nanoprobes for target identification of atherosclerosis.
Ma R; Hao L; Cheng J; He J; Yin Q; Li Z; Qi G; Zheng X; Wang D; Zhang T; Cong H; Li Z; Hu H; Wang Y
Biochem Biophys Res Commun; 2024 Apr; 702():149627. PubMed ID: 38340655
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the Diagnostic Performances of Ultrasound, High-Resolution Magnetic Resonance Imaging, and Positron Emission Tomography/Computed Tomography in a Rabbit Carotid Vulnerable Plaque Atherosclerosis Model.
Xu L; Wang R; Liu H; Wang J; Liang W; Mang J; Xu Z
J Ultrasound Med; 2020 Nov; 39(11):2201-2209. PubMed ID: 32395879
[TBL] [Abstract][Full Text] [Related]
31. Unambiguous detection of atherosclerosis using bioorthogonal nanomaterials.
Pellico J; Fernández-Barahona I; Benito M; Gaitán-Simón Á; Gutiérrez L; Ruiz-Cabello J; Herranz F
Nanomedicine; 2019 Apr; 17():26-35. PubMed ID: 30654185
[TBL] [Abstract][Full Text] [Related]
32. Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging: From Mice to Nonhuman Primates.
Calcagno C; Pérez-Medina C; Mulder WJM; Fayad ZA
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1123-1134. PubMed ID: 32237905
[TBL] [Abstract][Full Text] [Related]
33. Molecular imaging nanoprobes for theranostic applications.
He H; Zhang X; Du L; Ye M; Lu Y; Xue J; Wu J; Shuai X
Adv Drug Deliv Rev; 2022 Jul; 186():114320. PubMed ID: 35526664
[TBL] [Abstract][Full Text] [Related]
34. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
Wang X; Peter K
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
[TBL] [Abstract][Full Text] [Related]
36. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
[TBL] [Abstract][Full Text] [Related]
37. Near-Infrared Persistent Luminescence Nanoprobe for Early Detection of Atherosclerotic Plaque.
Luo X; Shi J; Wang R; Cao L; Gao Y; Wang J; Hong M; Sun X; Zhang Y
ACS Nano; 2024 Feb; 18(8):6500-6512. PubMed ID: 38348833
[TBL] [Abstract][Full Text] [Related]
38. Targeting the Microenvironment of Vulnerable Atherosclerotic Plaques: An Emerging Diagnosis and Therapy Strategy for Atherosclerosis.
Zhang S; Liu Y; Cao Y; Zhang S; Sun J; Wang Y; Song S; Zhang H
Adv Mater; 2022 Jul; 34(29):e2110660. PubMed ID: 35238081
[TBL] [Abstract][Full Text] [Related]
39. A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque.
Martínez-Parra L; Piñol-Cancer M; Sanchez-Cano C; Miguel-Coello AB; Di Silvio D; Gomez AM; Uriel C; Plaza-García S; Gallego M; Pazos R; Groult H; Jeannin M; Geraki K; Fernández-Méndez L; Urkola-Arsuaga A; Sánchez-Guisado MJ; Carrillo-Romero J; Parak WJ; Prato M; Herranz F; Ruiz-Cabello J; Carregal-Romero S
ACS Nano; 2023 Jul; 17(14):13811-13825. PubMed ID: 37399106
[TBL] [Abstract][Full Text] [Related]
40. Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque.
Mushenkova NV; Summerhill VI; Zhang D; Romanenko EB; Grechko AV; Orekhov AN
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]